{"symbol": "PIRS", "companyName": "Pieris Pharmaceuticals Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.pieris.com", "description": "Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing Anticalin class of biotherapeutics for patients with diseases in which there is high unmet medical needs.", "CEO": "Stephen S. Yoder", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}